Disclaimer

The following restricted pages of the website of Care Property Invest NV (the “Company”) contain information in respect of a contemplated transaction by the Company. Nothing on this website (or any website to which this website has been hypertext linked) constitutes an invitation or offer to acquire any securities of the Company or any of its subsidiaries.

THE INFORMATION IN THE FOLLOWING PAGES IS NOT INTENDED FOR, AND IS NOT TO BE MADE AVAILABLE TO, ANY PERSON THAT IS RESIDING, DOMICILED OR PHYSICALLY PRESENT IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SWITZERLAND OR SOUTH AFRICA.

The following information may only be consulted by investors that may have access to such information as allowed under the applicable regulations. These documents are made available for information purposes only. The reproduction of these electronic versions (i) on another website or at any other virtual or physical location, or (ii) in a printed form or on any other carrier for the purpose of distributing these documents, in any manner whatsoever, is strictly forbidden.

The information is made available for information purposes only and is not in any manner intended to constitute an offer or invitation to proceed to an acquisition of, or subscription to, any of the Company’s securities in, or towards residents, inhabitants, or citizens of, the United States of America, Canada, Australia, Japan, Switzerland, South Africa or any other jurisdiction where such offering or solicitation is not permitted without registration, exemption from registration or qualification under the applicable legislation of the relevant jurisdiction, or does not meet the required conditions under the applicable legislation of the relevant jurisdiction.

The information contained on this website and in the following information does not constitute an offer of securities for sale in the United States of America, Australia, Canada, Japan, South Africa, Switzerland or in any other jurisdiction in which such offers or sales are unlawful. The Company’s securities have not been, nor will be, registered under the United States Securities Act of 1933, as amended (the “US Securities Act”), or with any other securities regulatory authority of any state or other jurisdiction in the United States of America. There will be no public offer of securities in the United States of America.

The Company’s securities may not be offered or sold in the United States of America without prior registration under the US Securities Act, or unless the transaction is exempt from, or not subject to, the registration requirements of the US Securities Act and any applicable state securities laws.

No information contained in the following information, or any copy thereof, may, directly or indirectly, be taken or sent to, or distributed in, the United States of America, Canada, Australia, Japan, Switzerland, South Africa or any other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. Non-compliance with these provisions may constitute a breach of the applicable legislation in the United States of America, Canada, Australia, Japan, Switzerland, South Africa or any other applicable jurisdiction. The dissemination of information contained in the following information or on the Company’s website may be subject to legal restrictions and persons who become aware of and/or receive such information must inform themselves about any applicable legal restrictions and must comply with such restrictions.

In relation to each Member State of the European Economic Area and the United Kingdom (each a “Relevant State”), the following information is only addressed to and is only directed at qualified investors in that Relevant State within the meaning of Regulation ((EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, and any implementing measure in each relevant Member State of the EEA (the “Prospectus Regulation”)) (“Qualified Investors”).

In general, any person who would like to receive access to the following information must verify in advance that such access does not constitute a breach of any applicable law or regulations. The Company cannot be held liable should these restrictions be breached by any person.

While the Company has taken reasonable care to ensure that the information on this website (other than information accessed by hyperlink) is accurate at the time of last revision of the website, the Company accepts no liability for the accuracy or completeness or use of, nor any liability to update, the information contained on this website. The information on the Company’s website or contained in the following information should not be construed to constitute any form of advice or recommendation, including but not limited to investment, tax, legal or other advice, and should not be relied upon as the basis for any decision or action. In particular, actual results and developments may differ in a material manner from any forecast, forward-looking statement, opinion or expectation expressed in the following information or on the Company’s website.

By selecting “yes, I confirm and certify”, you will be granted access to the following electronic information, provided that:

  • a. you confirm and certify that you have read, understand and will comply with, the warnings and restrictions stated above; and
  • b. you confirm and certify that:
    1. you are not domiciled or a resident of, and are not accessing this information from, the United States of America, Australia, Canada, Japan or South Africa;
    2. you are not a US person (as defined in Regulation S under the US Securities Act);
    3. you are a Qualified Investor within the meaning of Prospectus Regulation 2017/1129;
    4. you do not live, reside or are located in any other jurisdiction where the distribution of this information is not legally permitted;
    5. you are a person who may and is permitted to receive this information; and
    6. in all circumstances, you agree not to transmit or otherwise send any information from this website to any person who may not receive this information or would otherwise breach applicable laws and regulations or would require registration or licensing.

-v23062020-

CAPITAL INCREASE

Capital increase – June 2020

Capital increase in cash via an accelerated bookbuild offering within the authorised capital with cancellation of the preferential subscription right  and without allocation of an irreducible allocation right through the issuance of max. 2,191,821 new shares.

Optional dividend – May/June 2020

Capital increase in kind – 15 January 2020

Acquisition of 2 residential care centres with assisted living apartments in Mons and Bernissart through a contribution in kind. Capital increase and strengthening of equity by approximately €33.6 million.

Optional dividend – May/June 2019

Capital increase in kind – 3 April 2019

Acquisition of a residential care centre in Genval through a contribution in kind. Capital increase and strengthening of equity by approximately €16.4 million.

Capital increase in cash – October 2017

Public Offering for subscription to New Shares in the context of a capital increase in cash, within the authorised capital, with Irrevocable Allocation Right for a maximum amount of EUR 72,138,612.00.

Press releases

Prospectus

The Prospectus for the public offering for subscription to New Shares consists of the Summary, the Registration Document and the Securities Note, including all information incorporated by reference.
The Securities Note, the Registration Document and the Summary may be distributed separately. The Securities Note, the Registration Document and the Summary are available in Dutch. The Registration Document and the Summary are also available in English and French. The English and French versions of the Summary are translations of the Dutch version of the Summary and are the responsibility of the Company. The Dutch version prevails over the other language versions.

12 October 2017 – Summary

12 October 2017- Securities Note (Available in Dutch only)

12 October 2017- Registration document: Annual Financial report 2016

12 October 2017- Half-yearly financial report 2017, published 7 September 2017

Presentation

11 October 2017- Roadshow presentation

Board of Directors

15 March 2017 : Acquisition of a residential care centre with service flats in Watermaal-Bosvoorde through contribution in kind. Capital increase and increase in equity of approx. EUR 33.5 million

Capital increase June 2015

Public offer for subscription to new shares within the framework of a capital increase in cash with irrevocable allocation right for a maximum amount of EUR 40,260,453.75

The Summary, together with the Registration Document and the Securities Note, including all information incorporated by reference, constitutes the Prospectus relating to the public offer for subscription to the New Shares. The Securities Note, the Registration Document and the Summary may be distributed separately. The Summary is available in Dutch, French and English. The translations of the Summary are performed at the responsibility of the Company. The Registration Document and the Securities Note are available in Dutch. The present Dutch-language version of the Summary has probative value.

Capital increase – 03-06-2015: Summary.

Capital increase – 03-06-2015: Securities Note (Verrichtingsnota) (available in Dutch only).

Capital increase – 03-06-2015: Registration Document (Registratiedocument – Jaarlijks Financieel Verslag voor de periode 01.01.2014 tot 31.12.2014) (available in Dutch only)

Capital increase